PharmaVOICE - 
October 2012
Purchase Issue

In Every Issue
Last Word
Developing a Patient-Centric Business Model Rob Bazemore, President of Janssen [...]
By

Rob Basemore, President, Janssen Biotech

Talent Pool
Pharmaceutical Pool Dr. Lawrence Bloch Infinity Names Business Chief Lawrence Bloch, [...]
By

Carolyn Gretton

PharmaTrax
Sales, marketing, And R&D?Trends affecting the healthcare industry Oncologists Rate [...]
By

Carolyn Gretton

Social Media
Social Media Innovators Move Beyond Corporate Facebook Pages Trend: More [...]
By

Robin Robinson

Tools of the Trade
New electronic and web-based applications, sites, and technologies Physicians Interactive [...]
By

Carolyn Gretton

What’s New
DIA and HBA Collaborate on Women’s Leadership Project Trend: The [...]
By

Carolyn Gretton

UpFront
Awards… Amylin’s Diabetes Product Honored Amylin’s Bydureon has been honored [...]
By

Taren Grom, Editor

Letter from the Editor
The Long Goodbye: Alzheimer’s Disease The numbers are almost as [...]
By

Taren Grom, Editor

On The Cover

Industry Spotlight: The Man, the Molecule, the Market: Untangling Alzheimer’s Mystery
Alzheimer’s disease is a progressive brain disorder that damages and eventually destroys brain cells, leading to loss of memory, thinking, and other brain functions. Alzheimer’s is not a part of normal aging, but results from a complex pattern of abnormal changes. It usually develops slowly and gradually worsens as more brain cells wither and die. [...]
By

Taren Grom, Editor, Denise Myshko, and Robin Robinson

Features

Compliance Issues? First, Don’t Panic.
A hurricane is coming. You heard about it on the radio. Everyone in the family jumps to it. You rush to the grocery store and pile as many cans of Chef Boyardee as will fit in your cart. Your spouse nails boards across the windows. The kids run around the house collecting candles. But when [...]
By

Greg Kain, Manager, Intergrated Project Management Company

SHOWCASE FEATURE: Regulatory Affairs: Regulating the Globe
The growing pressure on pharma companies and regulators to ensure and enforce product potency and safety has resulted in a strong trend toward harmonization among regulatory bodies throughout the world. “Regulatory professionals can no longer operate with a local-only mentality; every product and regulatory decision must consider a global perspective.” The FDA report, Pathway to [...]
By

Carolyn Gretton

China’s Pharma Star Shines Bright
With a large patient population, government commitment to healthcare reform, a huge depth of scientific talent, and a powerful economy, China has been identified by many as the world’s most important emerging biopharma market. With a population of 1.3 billion people, China is both the world’s most populous nation and the fastest-growing major economy. China [...]
By

Kim Ribbink

Take Charge of Your Career: Next Steps
Experts discuss the importance of mentoring, sponsorship, and coaching in career development. Mentoring has been a common tool to help employees learn from and take advantage of the experience of others. A consensus among our experts is that all employees can benefit from having mentors at different stages of their careers, especially in the pharmaceutical [...]
By

Denise Myshko

Segmentation and Personalization Brings Targets into Focus
With the tools that are available today, the industry can hone in on the right targets. Sophisticated technology and a more diverse field of targets are creating a new segmentation model that moves away from the practice of solely monitoring prescribing behaviors. The new environment requires strategies that can effectively determine the most appropriate channels [...]
By

Robin Robinson

A Changing Mindset: Managing Managed Markets
The industry must revamp its managed markets strategies from the ground up to survive in the new reality of value propositions. Since the onset of healthcare reform, the role and power of payers have been growing steadily and has reached a point of painful reality for the industry. Starting today, companies need to abandon knee-jerk [...]
By

Robin Robinson

FEEDBACK